Capitulo 1

Capitulo 2

Capitulo 3

Capitulo 4

Capitulo 5

Capitulo 6

Capitulo 7

Capitulo 8

Capitulo 6: Diabetes

• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-13.
• Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339:229-234.
• Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M. Consensus Workshop Group. Type 2 diabetes in the young: the evolving epidemic; the international Diabetes Federetion consensus workshop. Diabetes Care 2004; 27:1798-1811.
• Tuomilehto, Jaakko, Lindstrom, Jaana, Eriksson, Johan G., Valle, Timo T., Hamalainen, Helena, the Finnish Diabetes Prevention Study Group, Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. N Engl J Med 2001; 344:1343-1350.
• Diabetes Prevention Program Research Group, Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin N Engl J Med 2002; 346:393-403.
• ADA. Gestacional Diabetes Mellitus. Diabetes Care, 22 (Supl. 1): S 74. 1999.
• ADA: Clinical Practice Recommendations 2003. Diabetes Care, Vol. 26 Supl 1. Jan 2003.
• Am J Public Health. 1982 January; 72(1): 51–53. The North Karelia Project: What it tells us about the prevention of cardiovascular disease. E H Wagner.
• American Diabetes Association: Screening for type 2 diabetes. Diabetes Care 2003; 26:S21-S24.
• Chiasson J, Jose R, Gomis R y col, for the STOP-NIDDM Trial Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002; 15:2072-2077.
• Holman R, North B, Tunbridge F: Possible prevention of type 2 diabetes with acarbose or metformin. Diabetes 2000; 49(Suppl 1):450.
  WHO - The World Health Report 2002: Reducing risks, promoting healthy life. Geneve, 2002.
• 2.- Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999; 353(9164):1547-1557.